Skip to main content
. 2021 Mar 17;26(6):e1073–e1082. doi: 10.1002/onco.13716

Figure 1.

Figure 1

Distribution of chemotherapeutic regimens analyzed for which neurokinin‐1 receptor antagonist–based antiemetic prophylaxis is recommended (n = 489,049 treatments). Abbreviations: AC, anthracycline‐cyclophosphamide; HEC, highly emetogenic chemotherapy.